[Commentary] On April 8, the State Council Joint Defense and Joint Control Mechanism held a press conference in Beijing to introduce the production security of medical supplies.
[Explanation] After the outbreak of the New Coronary Pneumonia, the demand for medical supplies has shown explosive growth, and it is difficult to find a global mask. At the press conference, the relevant person in charge of the Ministry of Industry and Information Technology said that through full mobilization to resume production, China's medical equipment assets such as masks, protective clothing, isolating eye masks / face masks can increase significantly.
[Same period] Cao Xuejun, Deputy Director of the Consumer Goods Industry Department of the Ministry of Industry and Information Technology
As of April 5, the daily capacity of disposable medical protective clothing reached more than 1.5 million pieces, the daily capacity of medical N95 masks exceeded 3.4 million, the daily capacity of medical isolation masks / eye masks reached 290,000, and the daily capacity of automatic infrared thermometers1 Ten thousand units, the daily production capacity of handheld infrared thermometers is 400,000 units.
[Explanation] Cao Xuejun said that from the perspective of supply and demand, anti-epidemic assets can basically meet domestic demand. At present, enterprises are trying their best to organize exports. The relevant person in charge also said that although China is a major producer of medical supplies, its capacity is limited in the face of huge international demand, and it is also constrained by many factors.
[Same period] Huang Libin, Spokesperson of the Ministry of Industry and Information Technology and Director of the Operation Monitoring and Coordination Bureau
For example, the production of ventilator, which is concerned by the global media, is restricted by the insufficient supply of global core components. China's production capacity is less than 1/5 of the world's production capacity. Even if the supply of key components is guaranteed, we want to fully meet the global epidemic prevention Control needs are also unrealistic.
[Commentary] Huang Libin said that despite this, China is willing to provide assistance within its ability to the international community.
[Same period] Huang Libin, Spokesperson of the Ministry of Industry and Information Technology and Director of the Operation Monitoring and Coordination Bureau
When China's epidemic prevention and control situation is improving and the spread of foreign epidemics is accelerating, we are willing to provide support and assistance within the capabilities of relevant countries and regions, and encourage enterprises to use high-quality Chinese products to serve the international community.
[Commentary] The relevant person in charge also pointed out that in order to make positive contributions to the global epidemic prevention and control, the Ministry of Industry and Information Technology actively promotes domestic enterprises to increase production capacity; on the other hand, it urges enterprises to do a good job in quality control and guides enterprises to strictly control China and exporting countries. Standard organization production.
[Same period] Chen Kelong, Deputy Director of the First Division of the Equipment Industry of the Ministry of Industry and Information Technology
At present, China's ventilator manufacturers are working overtime, doing everything possible to provide product support for global anti-epidemic, and in accordance with the principle of marketization, conducting business negotiations with international purchasers.
[Explanation] Talking about the supply of key medicines, Cao Xuejun said that the production capacity recovery rate of the monitored products has reached normal levels, most products are in sufficient supply, and key drugs such as chloroquine phosphate and fapiravir have also been fully restored in early February.
[Same period] Cao Xuejun, Deputy Director of the Consumer Goods Industry Department of the Ministry of Industry and Information Technology
Up to now, the daily production capacity of chloroquine phosphate has reached 100,000, with a cumulative production of 670,000; the daily production capacity of Abidor is 50,000, with a cumulative production of 800,000; the daily production of fapiravir is 11,500. A total of 137,500 people were produced.
[Explanation] Cao Xuejun pointed out that in the next step, the Ministry of Industry and Information Technology will continue to strengthen production scheduling, coordinate and solve practical difficulties encountered in the production of enterprises, and make every effort to guarantee the production and supply of key drugs.
Reporter Liu Chao from Beijing
Editor in charge: [Liu Xian]